NJ State Employees Deferred Compensation Plan’s Array Biopharma Inc ARRY Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20,000	Closed	-$326K	–	537
2018 Q1	$326K	Sell	20,000 -25,000	-56%	-$400K	0.06%	399
2017 Q4	$576K	Hold	45,000	–	–	0.1%	305
2017 Q3	$554K	Sell	45,000 -15,000	-25%	-$139K	0.1%	300
2017 Q2	$502K	Hold	60,000	–	–	0.09%	284
2017 Q1	$536K	Hold	60,000	–	–	0.1%	267
2016 Q4	$527K	Hold	60,000	–	–	0.1%	264
2016 Q3	$405K	Hold	60,000	–	–	0.08%	283
2016 Q2	$214K	Hold	60,000	–	–	0.05%	335
2016 Q1	$189K	Hold	60,000	–	–	0.04%	350
2015 Q4	$253K	Hold	60,000	–	–	0.05%	332
2015 Q3	$274K	Hold	60,000	–	–	0.06%	324
2015 Q2	$433K	Hold	60,000	–	–	0.08%	297
2015 Q1	$442K	Hold	60,000	–	–	0.09%	300
2014 Q4	$284K	Hold	60,000	–	–	0.06%	334
2014 Q3	$214K	Hold	60,000	–	–	0.04%	358
2014 Q2	$274K	Hold	60,000	–	–	0.05%	348
2014 Q1	$282K	Hold	60,000	–	–	0.06%	343
2013 Q4	$301K	Hold	60,000	–	–	0.06%	341
2013 Q3	$373K	Hold	60,000	–	–	0.08%	323
2013 Q2	$272K	Buy	+60,000	New	+$323K	0.06%	347

Other funds holding ARRY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's ARRY Position: Q2 2018 in Review

NJ State Employees Deferred Compensation Plan sold out of Array Biopharma Inc (ARRY) in Q2 2018, closing a stake of 20,000 shares — an estimated $326K sold.

NJ State Employees Deferred Compensation Plan first reported a position in ARRY in Q2 2013 and held it in 20 quarters. The position peaked at $576K in Q4 2017. 223 funds tracked by Wall St. Rank hold ARRY as of Q2 2018.

NJ State Employees Deferred Compensation Plan reported no remaining Array Biopharma Inc position as of Q2 2018 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 20,000 Array Biopharma Inc shares in Q2 2018, an estimated $326K.
NJ State Employees Deferred Compensation Plan first reported a position in Array Biopharma Inc in Q2 2013 and held it in 20 quarters.
NJ State Employees Deferred Compensation Plan's Array Biopharma Inc position peaked at $576K in Q4 2017.
223 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2018.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2018, filed 2 Aug 2018.